PRLD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 62.80%

Insider Buying (Last 12 Months): $781,961.25

Insider Selling (Last 12 Months): $0.00

Prelude Therapeutics Insider Trading History Chart

Prelude Therapeutics Share Price & Price History

^$0.87

▼ -0.0204 (-2.30%)

As of 05/5/2025 11:42 AM ET

Days: 30 | 90 | 365

Prelude Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/25/2025	Andrew Combs	Insider	Buy	100,000	$0.69	$69,000.00	480,123
3/25/2025	Krishna Vaddi	CEO	Buy	675,000	$0.69	$465,750.00	1,999,296
3/12/2025	Krishna Vaddi	CEO	Buy	47,500	$0.71	$33,725.00	1,214,775
12/30/2024	Krishna Vaddi	CEO	Buy	10,000	$1.20	$12,000.00	137,553
12/23/2024	Andrew Combs	Insider	Buy	60,000	$1.37	$82,200.00	377,623
12/20/2024	Andrew Combs	Insider	Buy	3,075	$1.15	$3,536.25	317,623
12/19/2024	Bryant David Lim	CFO	Buy	25,000	$0.91	$22,750.00	27,400
12/18/2024	Krishna Vaddi	CEO	Buy	100,000	$0.93	$93,000.00	1,167,275
5/24/2023	Krishna Vaddi	CEO	Buy	1,000	$5.01	$5,010.00	1,066,375
5/22/2023	Orbimed Advisors Llc	Director	Buy	869,565	$5.75	$4,999,998.75	10,119,756
4/6/2023	Jane Huang	CMO	Sell	13,280	$6.12	$81,273.60	24,220
12/20/2022	Krishna Vaddi	CEO	Buy	19,188	$5.13	$98,434.44	120,665
12/8/2022	Laurent Chardonnet	CFO	Buy	10,000	$4.76	$47,600.00	35,873
6/1/2022	Laurent Chardonnet	CFO	Buy	10,000	$4.23	$42,300.00	24,500

See Full Table

SEC Filings (Institutional Ownership Changes) for Prelude Therapeutics (NASDAQ:PRLD)

79.72% of Prelude Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Prelude Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/17/2025	Two Sigma Investments LP	231,839	$0.30M	0.0%	+307.2%	0.421%
2/17/2025	Two Sigma Advisers LP	300,000	$0.38M	0.0%	+526.3%	0.545%
2/17/2025	Millennium Management LLC	462,555	$0.59M	0.0%	+188.2%	0.841%
2/17/2025	Jacobs Levy Equity Management Inc.	666,574	$0.85M	0.0%	+280.9%	1.211%
2/17/2025	Deutsche Bank AG	123,899	$0.16M	0.0%	+747.6%	0.225%
2/17/2025	Bridgeway Capital Management LLC	111,000	$0.14M	0.0%	-37.0%	0.202%
2/17/2025	BNP Paribas Financial Markets	20,572	$26K	0.0%	N/A	0.037%
2/14/2025	Boxer Capital Management LLC	1,708,187	$2.18M	0.2%	N/A	3.104%
2/14/2025	Northern Trust Corp	83,387	$0.11M	0.0%	-21.6%	0.152%
2/14/2025	Price T Rowe Associates Inc. MD	1,029,199	$1.31M	0.0%	-6.2%	1.870%
2/13/2025	Marshall Wace LLP	392,155	$0.50M	0.0%	+9.2%	0.713%
2/13/2025	Renaissance Technologies LLC	634,500	$0.81M	0.0%	+222.2%	1.153%
2/12/2025	Massachusetts Financial Services Co. MA	494,497	$0.63M	0.0%	-10.0%	0.899%
2/12/2025	JPMorgan Chase & Co.	61,149	$78K	0.0%	+925.0%	0.111%
2/6/2025	Charles Schwab Investment Management Inc.	117,200	$0.15M	0.0%	-12.0%	0.213%
1/30/2025	Rhumbline Advisers	166,830	$0.21M	0.0%	+1,289.8%	0.303%
11/19/2024	Barclays PLC	27,165	$57K	0.0%	+86.0%	0.049%
11/16/2024	Geode Capital Management LLC	391,716	$0.81M	0.0%	+8.2%	0.712%
11/15/2024	Barclays PLC	27,165	$57K	0.0%	+86.0%	0.049%
11/15/2024	XTX Topco Ltd	48,239	$100K	0.0%	N/A	0.088%
11/15/2024	State Street Corp	286,046	$0.59M	0.0%	+35.1%	0.520%
11/15/2024	Jacobs Levy Equity Management Inc.	174,979	$0.36M	0.0%	+885.2%	0.318%
11/14/2024	Walleye Capital LLC	83,175	$0.17M	0.0%	+446.2%	0.151%
11/12/2024	Massachusetts Financial Services Co. MA	549,530	$1.14M	0.0%	+5.2%	0.999%
10/10/2024	Exchange Traded Concepts LLC	64,409	$0.13M	0.0%	+32.2%	0.153%
8/15/2024	The Manufacturers Life Insurance Company	70,045	$0.27M	0.0%	-3.1%	0.166%
8/9/2024	Renaissance Technologies LLC	206,600	$0.79M	0.0%	-15.6%	0.491%
8/9/2024	Dimensional Fund Advisors LP	29,074	$0.11M	0.0%	+103.2%	0.069%
8/9/2024	Massachusetts Financial Services Co. MA	522,375	$1.99M	0.0%	+2.8%	1.241%
7/26/2024	Bank of New York Mellon Corp	36,276	$0.14M	0.0%	-9.5%	0.086%
5/16/2024	Kennedy Capital Management LLC	25,035	$0.12M	0.0%	N/A	0.059%
5/15/2024	Price T Rowe Associates Inc. MD	941,971	$4.47M	0.0%	-9.7%	2.239%
5/10/2024	Acadian Asset Management LLC	22,110	$0.10M	0.0%	+42.7%	0.053%
5/10/2024	Vanguard Group Inc.	1,016,999	$4.82M	0.0%	+1.0%	2.417%
2/15/2024	Boxer Capital LLC	2,568,287	$10.97M	0.5%	+2.9%	4.684%
2/14/2024	Pale Fire Capital SE	63,581	$0.27M	0.0%	+106.6%	0.116%
1/12/2024	SG Americas Securities LLC	13,100	$56K	0.0%	N/A	0.024%
1/5/2024	Exchange Traded Concepts LLC	44,087	$0.19M	0.0%	+34.0%	0.080%
11/14/2023	Pale Fire Capital SE	30,781	$95K	0.0%	N/A	0.056%
11/13/2023	FMR LLC	5,131,433	$15.86M	0.0%	-13.6%	9.359%
11/7/2023	Barclays PLC	13,316	$42K	0.0%	+120.0%	0.024%
10/27/2023	TD Asset Management Inc	160,652	$0.50M	0.0%	+100.0%	0.293%
10/18/2023	Exchange Traded Concepts LLC	32,907	$0.10M	0.0%	+29.4%	0.060%
9/21/2023	Barclays PLC	6,052	$27K	0.0%	-41.4%	0.011%
8/15/2023	Boxer Capital LLC	2,495,018	$11.23M	0.5%	+256.9%	4.552%
8/9/2023	TD Asset Management Inc	80,326	$0.36M	0.0%	+182.4%	0.147%
7/20/2023	Exchange Traded Concepts LLC	25,428	$0.11M	0.0%	N/A	0.053%
5/16/2023	Boxer Capital LLC	699,047	$3.99M	0.2%	N/A	1.458%
5/1/2023	Virtu Financial LLC	11,201	$64K	0.0%	N/A	0.023%
2/14/2023	683 Capital Management LLC	28,631	$0.17M	0.0%	N/A	0.060%
2/13/2023	GSA Capital Partners LLP	47,801	$0.29M	0.0%	-11.8%	0.100%
2/10/2023	New York Life Investment Management LLC	82,000	$0.50M	0.0%	+11.7%	0.171%
2/9/2023	Citigroup Inc.	60,072	$0.36M	0.0%	+604.1%	0.126%
2/7/2023	Bleakley Financial Group LLC	22,325	$0.14M	0.0%	N/A	0.047%
11/15/2022	Caxton Associates LP	85,992	$0.57M	0.1%	+2.5%	0.180%
11/14/2022	PDT Partners LLC	12,641	$84K	0.0%	-71.1%	0.026%
11/9/2022	Massachusetts Financial Services Co. MA	513,293	$3.39M	0.0%	+7.3%	1.073%
10/25/2022	Denali Advisors LLC	8,200	$54K	0.0%	N/A	0.017%
8/16/2022	Corton Capital Inc.	15,586	$81K	0.1%	+42.8%	0.033%
8/16/2022	Delphia USA Inc.	16,940	$88K	0.1%	N/A	0.035%
8/13/2022	Massachusetts Financial Services Co. MA	478,525	$2.50M	0.0%	-0.7%	1.000%
8/12/2022	Virtus ETF Advisers LLC	24,005	$0.13M	0.0%	+84.0%	0.050%
7/19/2022	Commonwealth Equity Services LLC	16,617	$86K	0.0%	-18.8%	0.035%
5/11/2022	Massachusetts Financial Services Co. MA	482,119	$3.33M	0.0%	+2.8%	1.012%
5/11/2022	GSA Capital Partners LLP	23,201	$0.16M	0.0%	N/A	0.049%
5/6/2022	IndexIQ Advisors LLC	56,750	$0.39M	0.0%	N/A	0.119%
5/5/2022	New York State Common Retirement Fund	4,992	$34K	0.0%	-45.1%	0.010%
5/4/2022	Commonwealth Equity Services LLC	20,467	$0.14M	0.0%	-10.4%	0.043%
3/3/2022	Walleye Capital LLC	41,954	$0.52M	0.0%	N/A	0.089%
2/14/2022	PDT Partners LLC	35,907	$0.45M	0.0%	N/A	0.076%
2/14/2022	Virtus ETF Advisers LLC	13,815	$0.17M	0.1%	+119.6%	0.029%
2/14/2022	Point72 Hong Kong Ltd	3,872	$48K	0.0%	+141.7%	0.008%
2/11/2022	Ensign Peak Advisors Inc	8,080	$0.10M	0.0%	N/A	0.017%
2/11/2022	Parkwood LLC	12,667	$0.16M	0.0%	N/A	0.027%
2/10/2022	Qube Research & Technologies Ltd	23,384	$0.29M	0.0%	N/A	0.050%
2/10/2022	Massachusetts Financial Services Co. MA	468,797	$5.84M	0.0%	-0.7%	0.993%
2/8/2022	Swiss National Bank	27,500	$0.34M	0.0%	+34.1%	0.058%
2/1/2022	Qube Research & Technologies Ltd	23,384	$0.29M	0.0%	N/A	0.050%
1/31/2022	Commonwealth Equity Services LLC	22,832	$0.28M	0.0%	+69.4%	0.048%
12/14/2021	UBS Asset Management Americas Inc.	1,483,319	$46.35M	0.0%	+15.2%	3.142%
11/15/2021	Point72 Hong Kong Ltd	1,602	$50K	0.0%	N/A	0.003%
11/15/2021	Cubist Systematic Strategies LLC	21,755	$0.68M	0.0%	+26.5%	0.046%
11/15/2021	California State Teachers Retirement System	13,524	$0.42M	0.0%	-9.5%	0.029%
11/15/2021	Rock Springs Capital Management LP	362,359	$11.32M	0.2%	-5.2%	0.769%
11/15/2021	Morgan Stanley	756,787	$23.65M	0.0%	+472.6%	1.607%
11/12/2021	Credit Suisse AG	6,950	$0.22M	0.0%	N/A	0.015%
11/12/2021	Geode Capital Management LLC	249,172	$7.79M	0.0%	+11.6%	0.529%
11/10/2021	Goldman Sachs Group Inc.	8,659	$0.27M	0.0%	-53.5%	0.018%
11/10/2021	Citigroup Inc.	24,268	$0.76M	0.0%	-67.9%	0.052%
11/10/2021	Rafferty Asset Management LLC	36,936	$1.15M	0.0%	-25.8%	0.078%
11/10/2021	Alliancebernstein L.P.	13,700	$0.43M	0.0%	-23.5%	0.029%
11/10/2021	Massachusetts Financial Services Co. MA	472,246	$14.76M	0.0%	+25.9%	1.003%
11/9/2021	BlackRock Inc.	725,962	$22.69M	0.0%	+3.3%	1.542%
11/4/2021	Deutsche Bank AG	6,537	$0.21M	0.0%	-82.4%	0.014%
11/1/2021	SG Americas Securities LLC	8,691	$0.27M	0.0%	N/A	0.018%
10/29/2021	Commonwealth Equity Services LLC	13,482	$0.42M	0.0%	+23.4%	0.029%
8/17/2021	Logos Global Management LP	400,000	$11.45M	1.0%	N/A	0.852%
8/17/2021	Metropolitan Life Insurance Co NY	3,194	$91K	0.0%	+106,366.7%	0.007%
8/17/2021	Price T Rowe Associates Inc. MD	400,802	$11.48M	0.0%	-5.2%	0.854%
8/16/2021	UBS Asset Management Americas Inc.	1,287,735	$36.87M	0.0%	+100.3%	2.742%

Data available starting January 2016

See Full Table

Prelude Therapeutics Incorporated, a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT1419, a myeloid cell leukemia-1 inhibitor, which is in Phase 1 clinical trial for the treatment of selected relapsed/refractory myeloid or B-cell malignancies; PRT2527, a cyclin-dependent kinase, which is in Phase 1 clinical trial for the treatment of advanced solid tumors; PRT3645, a cyclin-dependent kinase 4/6 inhibitor, which is in Phase 1 clinical trial for the treatment of advanced and metastatic solid tumors; and PRT3879, a SMARCA2 selective protein degrader, which is in Phase 2/3 clinical trial for the treatment of advanced and metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.

Today's Range

Now: $0.87

$0.84

$0.89

50 Day Range

MA: $0.75

$0.61

$0.96

52 Week Range

Now: $0.87

$0.61

$6.80

Volume

7,498 shs

Average Volume

268,254 shs

Market Capitalization

$37.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.3

Who are the company insiders with the largest holdings of Prelude Therapeutics?: Prelude Therapeutics' top insider shareholders include:
Orbimed Advisors Llc (Director)
Krishna Vaddi (CEO)
Andrew Combs (Insider)
Bryant David Lim (CFO)
Learn More about top insider investors at Prelude Therapeutics.